The receptor binding domain of apolipoprotein E is responsible for its antioxidant activity

Biochemistry

Volumn 44, Issue 20, 2005, Pages 7577-7582

  Pham, Thomas ^a   Kodvawala, Ahmer ^a   Hui, David Y ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; ANTIOXIDANTS; BODY FLUIDS; LIPIDS; NEUROLOGY; OXIDATION;

ANTIOXIDANT ACTIVITY; APOLIPOPROTEIN E; CELL HOMEOSTASIS; LIPID ASSOCIATED PROTEINS;

PROTEINS;

ALKADIENE; APOLIPOPROTEIN E; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; ARGININE; COPPER; LOW DENSITY LIPOPROTEIN; LYSINE;

AMINO TERMINAL SEQUENCE; ANTIOXIDANT ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG INHIBITION; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; LIPID OXIDATION; METHYLATION; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; TANDEM REPEAT;

AMINO ACID SEQUENCE; ANTIOXIDANTS; APOLIPOPROTEIN E3; APOLIPOPROTEINS E; ARGININE; COPPER SULFATE; HUMANS; LDL-RECEPTOR RELATED PROTEIN 1; LIPID PEROXIDATION; LIPOPROTEINS, LDL; LYSINE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS;

EID: 18844375108     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi0472696     Document Type: Article

References (64)

1. Davignon, J., Gregg, R. E., and Sing, C. F. (1988) Apolipoprotein E polymorphism and atherosclerosis, Atherosclerosis 8, 1-21.
2. van Bockxmeer, F. M., Mamotte, C. D. S., Gibbons, F. R., and Taylor, R. R. (1994) Apolipoprotein E4 homozygosity - a determinant of restenosis after coronary angioplasty, Atherosclerosis 110, 195-202.
3. Tada, H. (2001) The E4 allele of apolipoprotein E is associated with increased restenosis after coronary angioplasty, Tokai J. Exp. Clin. Med. 26, 81-92.
4. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., and Pericak-Vance, M. A. (1993) Gene dosage of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science 261, 921-923.
5. Roses, A. D. (1996) Apolipoprotein E alleles as risk factors in Alzheimer's disease, Annu. Rev. Med. 47, 387-400.
6. Li, Y. J., Hauser, M. A., Scott, W. K., Martin, E. R., Booze, M. W., Qin, X. J., Walter, J. W., Nance, M. A., Haubble, J. P., Koller, W. C., Pahwa, R., Stern, M. B., Hiner, B. C., Jankovic, J., Goetz, C. G., Small, G. W., Mastaglia, F., Haines, J. L., Pericak-Vance, M. A., and Vance, J. M. (2004) Apolipoprotein E controls the risk and age at onset of Parkinson disease, Neurology 62, 2005-2009.
7. Caselli, R. J., Greaff-Radford, N. R., Reiman, E. M., Weaver, A., Osborne, D., Lucas, J., Uecker, A., and Thibodeau, S. N. (1999) Preclinical memory decline in cognitively normal apolipoprotein E-ε4 homozygotes, Neurology 53, 201-207.
8. Small, G. W., Chen, S. T., Komo, S., Ercoli, L., Bookheimer, S., Miller, K., Lavretsky, H., Saxena, S., Kaplan, A., Dorsey, D., Scott, W. K., Saunders, A. M., Haines, J. L., Roses, A. D., and Pericak-Vance, M. A. (1999) Memory self-appraisal in middle-aged and older adults with the apolipoprotein E-4 allele, Am. J. Psychiat. 156, 1035-1038.
9. Caselli, R. J., Reiman, E. M., Osborne, D., Hentz, J. G., Baxter, L. C., Hernandez, J. L., and Alexander, G. G. (2004) Longitudinal changes in cognition and behavior in asymptomatic carriers of the apoE ε4 allele, Neurology 62, 1990-1995.
10. Mahley, R. W., and Huang, Y. (1999) Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond, Curr. Opin. Lipidol. 10, 207-217.
11. Mahley, R. W., and Rall, S. C. (2000) Apolipoprotein E: Far more than a lipid transport protein, Annu. Rev. Genomics Hum. Genet. 1, 507-537.
12. Mensenkamp, A. R., Jong, M. C., van Goor, H., van Luyn, M. J. A., Bloks, V., Havinga, R., Voshol, P. J., Hofker, M. H., van Dijk, K. W., Havekes, L. M., and Kuipers, F. (1999) Apolipoprotein E participates in the regulation of very low-density lipoprotein-triglyceride secretion by the liver, J. Biol. Chem. 274, 35711-35718.
13. Tsukamoto, K., Maugeais, C., Glick, J. M., and Rader, D. J. (2000) Markedly increased secretion of VLDL triglycerides induced by gene transfer of apolipoprotein E isoforms in apoE-deficient mice, J. Lipid Res. 41, 253-259.
14. Mahley, R. W., and Ji, Z. S. (1999) Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E, J. Lipid Res. 40, 1-16.
15. Smith, J. D., Miyata, M., Ginsberg, M., Grigaux, C., Shmookler, E., and Plump, A. S. (1996) Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from a macrophage cell line to apolipoprotein acceptors, J. Biol. Chem. 271, 30647-30655.
16. Huang, Z. H., and Mazzone, T. (2002) ApoE-dependent sterol efflux from macrophages is modulated by scavenger receptor class B type I expression, J. Lipid Res. 43, 375-382.
17. Krimbou, L., Denis, M., Haidar, B., Carrier, M., Marcil, M., and Genest, J., Jr. (2004) Molecular interactions between apoE and ABCA1: impact on apoE lipidation, J. Lipid Res. 45, 839-848.
18. Weisgraber, K. H., Innerarity, T. L., Harder, K. J., Mahley, R. W., Milne, R. W., Marcel, Y. L., and Sparrow, J. T. (1983) The receptor-binding domain of human apolipoprotein E. Monoclonal antibody inhibition of binding, J. Biol. Chem. 258, 12348-12354.
19. Dyer, C. A., Cistola, D. P., Parry, G. C., and Curtiss, L. K. (1995) Structural features of synthetic peptides of apolipoprotein E that bind the LDL receptor, J. Lipid Res. 36, 80-88.
20. Kypreos, K. E., van Dijk, K. W., van der Zee, A., Havekes, L. M., and Zannis, V. I. (2001) Domains of apolipoprotein E contributing to triglyceride and cholesterol homeostasis in vivo. Carboxyl terminal region 203-299 promotes hepatic very low-density lipoprotein-triglyceride secretion, J. Biol. Chem. 276, 19778-19786.
21. Gillotte, K. L., Zaiou, M., Lund-Katz, S., Anantharamaiah, G. M., Holvoet, P., Dhoest, A., Palgunachari, M. N., Segrest, J. P., Weisgraber, K. H., Rothblat, G. H., and Phillips, M. C. (1999) Apolipoprotein-mediated plasma membrane microsolubilization. Role of lipid affinity and membrane penetration in the efflux of cellular cholesterol and phospholipid, J. Biol. Chem. 274, 2021-2028.
22. Swertfeger, D. K., and Hui, D. Y. (2001) Apolipoprotein E: A cholesterol transport protein with lipid transport-independent cell signaling properties, Front. Biosci. 6, d526-d535.
23. Riddell, D. R., and Owen, J. S. (1996) Inhibition of ADP-induced platelet aggregation by apoE is not mediated by membrane cholesterol depletion, Thromb. Res. 81, 597-606.
24. Riddell, D. R., Graham, A., and Owen, J. S. (1997) Apolipoprotein E inhibits platelet aggregation through the L-arginine:nitric oxide pathway. Implications for vascular disease, J. Biol. Chem. 272, 89-95.
25. Vitek, M. P., Snell, J., Dawson, H., and Colton, C. A. (1997) Modulation of nitric oxide production in human macrophages by apolipoprotein-E and amyloid beta peptide, Biochem. Biophys. Res. Commun. 240, 391-394.
26. Sacre, S. M., Stannard, A. K., and Owen, J. S. (2003) Apolipoprotein E (apoE) isoforms differentially induce nitric oxide production in endothelial cells, FEBS Lett. 540, 181-187.
27. Ishigami, M., Swertfeger, D. K., Hui, M. S., Granholm, N. A., and Hui, D. Y. (2000) Apolipoprotein E inhibition of vascular smooth muscle cell proliferation but not the inhibition of migration is mediated through activation of inducible nitric oxide synthase, Arterioscler. Thromb. Vasc. Biol. 20, 1020-1026.
28. Zhu, Y., and Hui, D. Y. (2003) Apolipoprotein E binding to low-density lipoprotein receptor-related protein-1 inhibits cell migration via activation of cAMP-dependent protein kinase A, J. Biol. Chem. 278, 36257-36263.
29. Herz, J., and Hui, D. Y. (2004) Lipoprotein receptors in the vessel wall, Curr. Opin. Lipidol. 15, 175-181.
30. Swertfeger, D. K., and Hui, D. Y. (2001) Apolipoprotein E receptor binding versus heparan sulfate proteoglycan binding in its regulation of smooth muscle cell migration and proliferation, J. Biol. Chem. 276, 25043-25048.
31. Nathan, B. P., Bellosta, S., Sanan, D. A., Weisgraber, K. H., Mahley, R. W., and Pitas, R. E. (1994) Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro, Science 264, 850-852.
32. Nathan, B. P., Chang, K. C., Bellosta, S., Brisch, E., Ge, N., Mahley, R. W., and Pitas, R. E. (1995) The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtuble depolymerization, J. Biol. Chem. 270, 19791-19799.
33. Strittmatter, W. J., Saunders, A. M., Goedert, M., Weisgraber, K. H., Dong, L. M., Jakes, R., Huang, D. Y., Pericak-Vance, M., Schmechel, D., and Roses, A. D. (1994) Isoform specific interactions of apolipoprotein E with microtubule-associated protein tau: Implications for Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A. 91, 11183-11186.
34. Wang, X. S., and Gruenstein, E. (1997) Rapid elevation of neuronal cytoplasmic calcium by apolipoprotein E peptide, J. Cell. Physiol. 173, 73-83.
35. Wang, X. S., Luebbe, P., Gruenstein, E., and Zemlan, F. (1998) Apolipoprotein E (apoE) peptide regulates tau phosphorylation via two different signaling pathways, J. Neurosci. Res. 51, 658-665.
36. Herz, J., and Strickland, D. K. (2001) LRP: a multifunctional scavenger and signaling receptor, J. Clin. Invest. 108, 779-784.
37. Herz, J. (2001) The LDL receptor gene family: (Un)expected signal transducers in the brain, Neuron 29, 571-581.
38. Miyata, M., and Smith, J. D. (1996) Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides, Nat. Genet. 14, 55-61.
39. Letters, J. M., Witting, P. K., Christison, J. K., Eriksson, A. W., Pettersson, K., and Stocker, R. (1999) Time-dependent changes to lipids and antioxidants in plasma and aortas of apolipoprotein E knockout mice, J. Lipid Res. 40, 1104-1112.
40. Lauderback, C. M., Kanski, J., Hackett, J. M., Maeda, N., Kindy, M. S., and Butterfield, D. A. (2002) Apolipoprotein E modulates Alzheimer's Aβ(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner, Brain Res. 924, 90-97.
41. Ihara, Y., Hayabara, T., Sasaki, K., Kawada, R., Nakashima, Y., and Kuroda, S. (2000) Relationship between oxidative stress and apoE phenotype in Alzheimer's disease, Acta Neurol. Scand. 102, 346-349.
42. LaDu, M., Falduto, M., Manelli, A., Reardon, C., Getz, G., and Frail, D. (1994) Isoform-specific binding of apolipoprotein E to β-amyloid, J. Biol. Chem. 269, 23403-23406.
43. Rall, S. C., Weisgraber, K. H., and Mahley, R. W. (1986) Isolation and characterization of apolipoprotein E, Methods Enzymol. 128, 273-287.
44. Weisgraber, K. H., Innerarity, T. L., and Mahley, R. W. (1978) Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts, J. Biol. Chem. 253, 9053-9062.
45. Mahley, R. W., Innerarity, T. L., Pitas, R. E., Weisgraber, K. H., Brown, J. H., and Gross, E. (1977) Inhibition of lipoprotein binding to cell surface receptors of fibroblast following selective modification of arginyl residues in arginine-rich and B apoproteins, J. Biol. Chem. 252, 7279-7287.
46. Wetterau, J. R., Aggerbeck, L. P., Rall, S. C., and Weisgraber, K. H. (1988) Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains, J. Biol. Chem. 263, 6240-6248.
47. Aggerbeck, L. P., Wetterau, J. R., Weisgraber, K. H., Wu, C. S. C., and Lindgren, F. T. (1988) Human apolipoprotein E3 in aqueous solution. II. Properties of the amino and carboxyl terminal domains, J. Biol. Chem. 263, 6249-6258.
48. Innerarity, T. L., Friedlander, E. J., Rall, S. C., Weisgraber, K. H., and Mahley, R. W. (1983) The receptor binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments, J. Biol. Chem. 258, 12341-12347.
49. Croy, J. E., Brandon, T., and Komives, E. A. (2004) Two apolipoprotein E mimetic peptides, apoE(130-149) and apoE-(141-155)2, bind to LRP1, Biochemistry 43, 7328-7335.
50. Li, X., Kypreos, K., Zanni, E. E., and Zannis, V. (2003) Domains of apoE required for binding to apoE receptor 2 and to phospholipids: Implications for the functions of apoE in the brain, Biochemistry 42, 10406-10417.
51. Dyer, C. A., Smith, R. S., and Curtiss, L. K. (1991) Only multimers of a synthetic peptide of human apolipoprotein E are biologically active, J. Biol. Chem. 266, 15009-15015.
52. Dyer, C. A., and Curtiss, L. K. (1991) A synthetic peptide mimic of plasma apolipoprotein E that binds to LDL receptor, J. Biol. Chem. 266, 22803-22806.
53. Weisgraber, K. H., Rall, S. C., Jr., Mahley, R. W., Milne, R. W., Marcel, Y. L., and Sparrow, J. T. (1986) Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3, J. Biol. Chem. 261, 2068-2076.
54. Swertfeger, D. K., and Hui, D. Y. (2001) Apolipoprotein E receptor binding versus heparan sulfate proteoglycan binding in its regulation of smooth muscle cell migration and proliferation, J. Biol. Chem. 276, 25043-25048.
55. Steinberg, D. (1997) Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherosclerosis, Circulation 95, 1062-1071.
56. Griendling, K. K., Sorescu, D., and Ushio-Fukai, M. (2000) NAD(P)H oxidase. Role in cardiovascular biology and disease, Circ. Res. 86, 494-501.
57. Coyle, J. T., and Puttfarcken, P. (1993) Oxidative stress, glutamate, and neurodegenerative disorders, Science 262, 689-695.
58. Palinski, W., Ord, V. A., Plump, A. S., Breslow, J. L., Steinberg, D., and Witztum, J. L. (1994) ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum, Arterioscler. Thromb. 14, 605-616.
59. Kagi, J. H. R., and Vallee, B. L. (1961) Metallothionein: a cadmium and zinc-containing protein from equine renal cortex. II. Physico-chemical properties, J. Biol. Chem. 236, 2435-2442.
60. Kojima, Y., Berger, C., Vallee, B. L., and Kagi, J. H. R. (1976) Amino acid sequence of equine renal metallothionein-1B, Proc. Natl. Acad. Sci. U.S.A. 73, 3413-3417.
61. Morrow, J. A., Hatters, D. M., Lu, B., Höchtl, P., Oberg, K. A., Rupp, B., and Weisgraber, K. H. (2002) Apolipoprotein E4 forms a molten globule. A potential basis for its association with disease, J. Biol. Chem. 277, 50380-50385.
62. Hara, M., Fujinaga, M., and Kuboi, T. (2004) Radical scavenging activity and oxidative modification of citrus dehydrin, Plant Physiol. Biochem. 42, 657-662.
63. Marques, M. A., Tolar, M., and Crutcher, K. A. (1997) Apolipoprotein E exhibits isoform-specific neurotoxicity, Alzheimer's Res. 3, 1-6.
64. Garber, D. W., Handattu, S., Aslan, I., Datta, G., Chaddha, M., and Anantharamaiah, G. M. (2003) Effect of an arginine-rich amphipathic helical peptide on plasma cholesterol in dyslipidemic mice, Atherosclerosis 168, 229-237.